Paper74723
Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?
Hubbard VS and 2 others. Lancet, 1977. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect? Papers, record 74723. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/74723
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Fatty Acids | Major topic |
| Lipids | Major topic |
| Adolescent | |
| Adult | |
| Female | |
| Heterozygote | |
| Humans | |
| Malabsorption Syndromes | |
| Male | |
| Middle Aged | |
| Oleic Acids | |
| Palmitic Acids | |
| Pancreas | |
| Phospholipids | |
| Triglycerides |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39620135 | Fatty acid abnormalities in cystic fibrosis-the missing link for a cure? | iScience | 2024 | https://conductscience.org/library/papers/39620135 | PubMed |
| 37297899 | Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial. | J Clin Med | 2023 | https://conductscience.org/library/papers/37297899 | PubMed |
| 36416119 | The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/36416119 | PubMed |
| 32982730 | The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32982730 | PubMed |
| 32394023 | The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. | Cell Mol Life Sci | 2020 | https://conductscience.org/library/papers/32394023 | PubMed |
| 32044291 | Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis. | Redox Biol | 2020 | https://conductscience.org/library/papers/32044291 | PubMed |
| 29167646 | Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications. | Front Physiol | 2017 | https://conductscience.org/library/papers/29167646 | PubMed |
| 25216340 | Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25216340 | PubMed |
| 18480495 | A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. | J Lipid Res | 2008 | https://conductscience.org/library/papers/18480495 | PubMed |
| 15869703 | Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency. | Nutr Metab (Lond) | 2005 | https://conductscience.org/library/papers/15869703 | PubMed |
| 7990664 | Serum fatty acid profiles in cystic fibrosis patients and their parents. | Lipids | 1994 | https://conductscience.org/library/papers/7990664 | PubMed |
| 6662144 | What is the association of essential fatty acid status with cystic fibrosis? | Eur J Pediatr | 1983 | https://conductscience.org/library/papers/6662144 | PubMed |
| 6641763 | Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. | Eur J Pediatr | 1983 | https://conductscience.org/library/papers/6641763 | PubMed |
| 6489383 | Fatty acid pattern of platelet phospholipids in cystic fibrosis. | Eur J Pediatr | 1984 | https://conductscience.org/library/papers/6489383 | PubMed |
| 3849459 | Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. | Gut | 1985 | https://conductscience.org/library/papers/3849459 | PubMed |
| 3678278 | Application of a new test for vitamin E deficiency to cystic fibrosis. | Eur J Pediatr | 1987 | https://conductscience.org/library/papers/3678278 | PubMed |
| 3646103 | Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. | Dig Dis Sci | 1987 | https://conductscience.org/library/papers/3646103 | PubMed |
| 3613873 | Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis. | Lipids | 1987 | https://conductscience.org/library/papers/3613873 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/74723
GET https://conductscience.org/api/papers/v1/74723/authors